Enzo Contract Claims Trimmed In Affymetrix Med Testing Row

Law360, Los Angeles (December 9, 2013, 6:44 PM EST) -- A New York federal judge on Friday pared most claims from Enzo Biochem Inc.’s suit alleging Affymetrix Inc. had breached a contract allowing it to distribute Enzo’s products for detecting nucleic acids, ruling Enzo had not provided enough information to back the claims up.

U.S. District Judge Richard J. Sullivan partially granted Affymetrix’s motion for summary judgment and tossed three of Enzo’s claims, including a claim that Affymetrix had not used reasonable efforts to sell Enzo’s chemical reagents under the terms of a 1998 distribution agreement....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.